床旁化学检测指导透析液调整以减少心律失常的初步试验
主要终点为治疗方案依从率,结果为85%(604/708次)。临床显著心律失常事件共45次,碱中毒避免期和钾清除最大化期数值上较少,但无显著差异。
要点
- 基于床旁检测的钾/碳酸氢盐调整算法可行,依从率85%。
- 未发生与研究干预相关的严重不良事件。
- 临床显著心律失常事件在碱中毒避免期和钾清除最大化期数值上较少,但无显著差异。
核心结论
- 基于床旁检测的钾/碳酸氢盐调整算法可行。
- 治疗间钾和碳酸氢盐变异性高,提示床旁-实验室指导算法可能显著改变透析液-血清化学梯度。
- 应考虑开展确定性终点把握度充分的试验。
研究设计与样本
- 四种干预为:钾清除最小化、钾清除最大化、酸中毒避免、碱中毒避免;每次治疗前根据床旁检测值调整透析液钾或碳酸氢盐。
主要发现
- 血液透析工作人员完成床旁检测并正确调整透析液的比例为604/708(85%)次可用治疗。
- 出现1次钾≤3 mEq/l、29次碳酸氢盐<20 mEq/l和2次碳酸氢盐>32 mEq/l,无与研究干预相关的严重不良事件。
- 床旁检测结果与同期常规实验室检测无显著差异,但治疗间钾和碳酸氢盐变异性高。
- 共45次临床显著心律失常事件,多数为一过性心房颤动;碱中毒避免期8次、钾清除最大化期3次,其他干预期17次,数值上较少。
- 各干预间临床显著心律失常持续时间无显著差异。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Excessive dialytic potassium (K) and acid removal are risk factors for arrhythmias; however, treatment-to-treatment dialysate modification is rarely performed. We conducted a multicenter, pilot randomized study to test the safety, feasibility, and efficacy of 4 point-of-care (POC) chemistry-guided protocols to adjust dialysate K and bicarbonate (HCO3) in outpatient hemodialysis (HD) clinics. METHODS: Participants received implantable cardiac loop monitors and crossed over to four 4-week periods with adjustment of dialysate K or HCO3 at each treatment according to pre-HD POC values: (i) K-removal minimization, (ii) K-removal maximization, (iii) Acidosis avoidance, and (iv) Alkalosis avoidance. The primary end point was percentage of treatments adhering to the intervention algorithm. Secondary endpoints included pre-HD K and HCO variability, adverse events, and rates of clinically significant arrhythmias (CSAs). RESULTS: Nineteen subjects were enrolled in the study. HD staff completed POC testing and correctly adjusted the dialysate in 604 of 708 (85%) of available HD treatments. There was 1 K ≤3, 29 HCO3 <20 and 2 HCO3 >32 mEq/l and no serious adverse events related to study interventions. Although there were no significant differences between POC results and conventional laboratory measures drawn concurrently, intertreatment K and HCO3 variability was high. There were 45 CSA events; most were transient atrial fibrillation (AF), with numerically fewer events during the alkalosis avoidance period (8) and K-removal maximization period (3) compared to other intervention periods (17). There were no significant differences in CSA duration among interventions. CONCLUSION: Algorithm-guided K/HCO3 adjustment based on POC testing is feasible. The variability of intertreatment K and HCO3 suggests that a POC-laboratory-guided algorithm could markedly alter dialysate-serum chemistry gradients. Definitive end point-powered trials should be considered.
引用
- Pun PH, Santacatterina M, Ways J, et al. Point-of-Care Chemistry-Guided Dialysate Adjustment to Reduce Arrhythmias: A Pilot Trial. Kidney Int Rep. 2023. PMID: 38025214. doi:10.1016/j.ekir.2023.07.039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。